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Spina bifida-predisposing 
heterozygous mutations in Planar 
Cell Polarity genes and Zic2 reduce 
bone mass in young mice
Isabel R. Orriss1, Stuart Lanham2, Dawn Savery3, Nicholas D. E. Greene3, Philip Stanier3, 
Richard Oreffo  2, Andrew J. Copp  3 & Gabriel L. Galea  3
Fractures are a common comorbidity in children with the neural tube defect (NTD) spina bifida. 
Mutations in the Wnt/planar cell polarity (PCP) pathway contribute to NTDs in humans and mice, 
but whether this pathway independently determines bone mass is poorly understood. Here, we first 
confirmed that core Wnt/PCP components are expressed in osteoblasts and osteoclasts in vitro. In vivo, 
we performed detailed µCT comparisons of bone structure in tibiae from young male mice heterozygous 
for NTD-associated mutations versus WT littermates. PCP signalling disruption caused by Vangl2 
(Vangl2Lp/+) or Celsr1 (Celsr1Crsh/+) mutations significantly reduced trabecular bone mass and distal tibial 
cortical thickness. NTD-associated mutations in non-PCP transcription factors were also investigated. 
Pax3 mutation (Pax3Sp2H/+) had minimal effects on bone mass. Zic2 mutation (Zic2Ku/+) significantly 
altered the position of the tibia/fibula junction and diminished cortical bone in the proximal tibia. 
Beyond these genes, we bioinformatically documented the known extent of shared genetic networks 
between NTDs and bone properties. 46 genes involved in neural tube closure are annotated with bone-
related ontologies. These findings document shared genetic networks between spina bifida risk and 
bone structure, including PCP components and Zic2. Genetic variants which predispose to spina bifida 
may therefore independently diminish bone mass.
Genetic analyses of rare human diseases associated with altered fracture risk have identified critical determinants 
of bone mass and architecture, some of which are now established clinical targets1. Fracture incidence in the gen-
eral population follows a biphasic epidemiological pattern with a high incidence in childhood, a low incidence fol-
lowing skeletal maturity, increasing again in women following the menopause and in both men and women with 
age2,3. Progress has been made in delineating the genetic and pathophysiological basis of osteoporosis-related fra-
gility fractures in the elderly4,5, whereas fractures during childhood have been less intensively studied. A number 
of genetic conditions presenting in childhood with primary skeletal disorders, such as osteogenesis imperfecta 
associated with mutations in the Wingless homology (Wnt) ligand Wnt16, are now recognised, while multigenic 
disorders such as Down’s syndrome are also directly associated with skeletal effects7.
Paediatric fractures are important comorbidities in rare and multigenic conditions that do not primarily pres-
ent with skeletal phenotypes, as is the case in paediatric spina bifida (myelomeningocele)8–11 patients. The best 
established risk factor for fractures in affected children is being non-ambulatory9,10, consistent with mechanical 
loading being the major functional determinant of bone mass and architecture. However, in a subset of patients 
primary skeletal disorders may also be involved. This is suggested by reports of fractures during childbirth and 
the neonatal period12,13 as well as low trauma fractures in ambulatory children11. Furthermore, differences in 
tibial mass and architecture in affected infants, independently of the degree of paralysis, have previously been 
described14. Specifically, tibiae from affected perinatal infants had smaller cortical area and thickness than 
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age-matched infants who died for unrelated reasons, and their cross-sectional geometry clustered into groups 
with normal, increased or decreased eccentricity (a perfect circle has an eccentricity of 0)14.
Spina bifida and associated neural tube defects (NTDs) continue to affect around 1:1,000 pregnancies, with 
higher incidence in some geographical areas such as Northern China and in high risk groups such as those who 
have previously had an affected pregnancy15,16. Two molecular pathways clearly associated with spina bifida risk 
in humans are folate metabolism and the planar cell polarity (PCP) pathway, a non-canonical branch of Wnt sig-
nalling16. In mice, over two hundred genes have been identified which, when mutated, result in NTDs including 
spina bifida17,18. Some of these, such as components of the bone morphogenetic protein pathway19, are very well 
established to have critical skeletal roles independently of their role in neural tube closure. This raises the hypoth-
esis that genetic variants which predispose to spina bifida may independently diminish bone mass. However the 
extent of the genetic commonalities between NTD risk and skeletal functional competence has not been system-
atically investigated.
Recently we reported that osteoblasts from NTD-predisposed Loop tail (Lp) mice which carry a heterozygous 
dominant negative mutation of Vangl2, a core PCP component, are less able to reorient their divisions follow-
ing mechanical strain in vitro20. The PCP pathway is highly conserved from mammals to Drosophila, in which 
its core components follow highly polarized distributions in embryonic epithelia21. The pathway is activated by 
non-canonical Wnt ligands such as Wnt5a binding to the frizzled (Fzd) Wnt co-receptors. These cluster with the 
trans-membrane proteins Vangl1/2 and Celsr1-3, recruiting intracellular proteins including scribbled (Scrib) and 
dishevelled (Dvl). The outcomes of PCP signalling include regulation of gene expression through the JNK/c-Jun 
pathway as well as cytoskeletal reorganisation through Rho/ROCK signalling.
The roles of this pathway in mammals have primarily been studied in cancer and in development, primarily 
due to its role in convergent extension movements which narrow and elongate the early embryo22. Homozygous 
Lp mutation results in shorter but wider and thicker early limb buds and digit pre-chondrogenic condensates, as 
well as delayed ossification and absence of the middle phalanx in all digits23. This phenotype is exacerbated by 
heterozygous deletion of the PCP ligand Wnt5a, whereas homozygous Wnt5a deletion results in near-complete 
absence of digit mineralisation23,24. The roles of Wnt5a in osteoblasts and osteoclasts have been extensively stud-
ied. Its expression increases biphasically during osteoblastic differentiation25 and it promotes osteoclastic resorp-
tion in association with its alternate receptor, receptor tyrosine kinase-like orphan receptor 226. However, whether 
its roles in postnatal bone include interactions with core PCP components are understudied.
We previously reported that Wnt5a mRNA increases rapidly in osteoblast-like cells subjected to strain in 
vitro20. In vivo, young female Vanlg2Lp/+ mice without spina bifida had lower distal femoral trabecular bone mass 
and a more circular mid-shaft cross-section than wild-type (WT) littermates20. This finding suggests that the 
PCP pathway influences post-natal bone mass and architecture and identifies a mouse genotype, known to be at 
increased risk of NTDs, which independently has low bone mass. This initial skeletal phenotyping was under-
taken at a single pre-selected site of the femur, however, recent methodological developments now allow system-
atic analyses of cross-sectional bone mass and architecture across the bone’s length. For example, Site Specificity 
Analysis (SSA)27, has demonstrated that locally- and systemically-acting interventions can have site-specific 
effects on bone. SSA analysis has not yet been applied to document the effects of PCP pathway disruption on bone 
mass and architecture.
In this study we determined the expression of core PCP components during osteoblast and osteoclast differ-
entiation in vitro. The relevance of this pathway to bone in vivo was investigated by applying SSA to study tibial 
structure in heterozygous Lp versus wild-type (WT) young male mice (assaying an additional bone and sex from 
that previously studied). To determine whether the roles of PCP signalling in bone extend beyond Vangl2, we 
similarly applied SSA to tibiae from Crash (Crsh) mice which carry a heterozygous mutation in another core 
PCP component, Celsr1, as well as in two non-PCP gene models, Splotch (Sp2H) and Kumba (Ku), which carry 
NTD-associated mutations in the transcription factors Pax3 and Zic2 respectively. Homozygous mutations 
of each of the genes tested result in NTDs with high or complete penetrance and render the mice non-viable, 
whereas a small proportion of heterozygous embryos develop spina bifida (Vangl2Lp/+ ~5%28, Celsr1Crsh/+ predis-
posed when modifier genes also mutated29, Pax3Sp/+ ~6%30, Zic2Ku/+ ~3%31). To determine whether commonal-
ities extend beyond the genes directly investigated here, we subsequently document the known extent of shared 
genetic networks between NTD risk and bone-related functions.
Results
Core mammalian Wnt/PCP components are expressed in bone cells. Core components of the 
mammalian Wnt/PCP pathway are expressed in osteoblasts and osteoclasts. Analysis of a previously-reported 
RNA-Seq dataset32 confirmed PCP pathway components are detectably expressed in bone and marrow of adult 
mice (Fig. 1A,B). In cultured osteoblasts, expression of Vangl2 and Celsr1 was increased in mature, mineralising 
osteoblasts (day 21) compared to differentiating cells (day 7). Vangl1 and Scrib mRNA expression was not sig-
nificantly altered during osteoblast differentiation (Fig. 1C). In contrast, Vangl1 and Scrib mRNA expression was 
increased in mature, actively resorbing osteoclasts (day 9, two days following medium acidification) compared to 
mature, inactive osteoclasts (day 7). Vangl2 and Celsr1 mRNA expression was unaffected by osteoclast activation. 
This data demonstrates that core PCP components are expressed in osteoblasts and osteoclasts.
Vangl2 mutation diminishes trabecular bone mass. Male mice carrying a heterozygous Vangl2 muta-
tion, Vangl2Lp/+, displayed diminished trabecular bone mass. Young male Vangl2Lp/+ mice had lower bone volume 
per tissue volume (BV/TV, −35.0% on average), trabecular number (Tb.N, −29.2%) and trabecular thickness 
(Tb.Th, −8.7%), and higher trabecular pattern factor (Tb.Pf, +5.7%) and structure model index (SMI, +18.7%) 
than Vangl2+/+ littermates (Fig. 2A–F). Trabecular separation (Tb.Sp) was unchanged (Supplementary Table S1).
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Detailed analysis of tibial cortical bone using SSA identified minimal effects of Vangl2Lp/+ mutation on cortical 
bone mass (Fig. 3). Cortical area (Ct.Ar) was 3.3% lower on average across all sites in tibiae from Vangl2Lp/+ than 
Vangl2+/+ mice (Fig. 3A) whereas total tissue area (Tt.Ar) was not significantly different (Fig. 3B). Medullary 
area (Ma.Ar) was bigger (+7.8% across all sites, Fig. 3C) whereas cross-sectional thickness (Cs.Th) was smaller 
(−3.7% across all sites, Fig. 3D) on average in tibiae from Vangl2Lp/+ mice. These differences were not associated 
with a significant change in polar moment of inertia (PMI, a computed parameter associated with bone strength, 
Fig. 3E). Although none of the differences overserved were site-specific (genotype * site interaction p > 0.10 in 
each case), the differences in Ct.Ar reached significance in the proximal tibiae (Fig. 3A) whereas differences in 
Ma.Ar and Cs.Th were significant at sites distal to the tibia/fibula junction (Fig. 3C,D).
Eccentricity, which is a measure of cross-sectional circularity rather than mass, was significantly higher in the 
proximal tibia of Vangl2Lp/+ than Vangl2+/+ mice (Fig. 3F).
Celsr1 mutation diminishes trabecular bone mass and mid-shaft cortical thickness. Mice car-
rying the heterozygous Celsr1 mutation, Celsr1Crsh/+, displayed diminished trabecular bone mass, similarly to that 
seen in heterozygous Loop tail mice, demonstrating other components of the PCP signalling pathway also con-
tribute to this bone compartment. Specifically, young Celsr1Crsh/+ male mice had lower BV/TV (−41.0%), Tb.N 
(−23.5%) and Tb.Th (−15.5%), and higher Tb.Pf (+44.4%) and SMI (+16.5%) than Celsr1+/+ mice (Fig. 4A–F 
and Supplementary Table S2).
In the tibial cortical compartment, the Crsh mutation in Celsr1 was associated with smaller Ct.Ar and Tt.Ar 
compared with Celsr1+/+ littermates (−11.0% and −5.7% on average across all sites respectively, Fig. 5A,B). 
Ma.Ar was regionally higher (Fig. 5C) in the same region of the tibia affected by mutation of Vangl2. The Crsh 
mutation had a more pronounced effect on Cs.Th (−14.7% across all sites), reducing it primarily in the distal tibia 
below the tibia-fibula junction, and consequently reducing PMI (−14.0% across all sites) significantly in the same 
region (Fig. 5D,E,E’). None of the differences observed were site-specific (genotype * site interaction p > 0.10 in 
each case).
Contrary to the effect of the Lp mutation, Crsh reduced eccentricity (Fig. 5F).
Figure 1. Core PCP pathway components are expressed in osteoblasts and osteoclasts. (A) Schematic 
illustration of components of the mammalian PCP pathway (based on Nikolopoulou et al.21). (B) Normalised 
detection levels of mammalian PCP components in bone marrow and tibial cortical bone from an RNA-Seq 
dataset previously reported by Ayturk et al.32. (C) qRT-PCR quantification of the core PCP components Vangl1, 
Vangl2, Celsr1 and Scrib in osteoblast cultures differentiated for 14 or 21 days, compared with osteoblasts 
cultured for 7 days (set at 1 for each set of cultures). (D) qRT-PCR quantification of Vangl1, Vangl2, Celsr1 and 
Scrib in mature resorbing osteoblasts versus mature osteoclasts (set at 1 for each culture). N = 4–6, *p < 0.05, 
**p < 0.01.
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Mutation of the non-PCP gene, Pax3 minimally affects bone mass. Pax3 mRNA expression was 
below the limit of reading in osteoblast and osteoclast cultures (CT > 35 cycles whereas CT values in E9.5 mouse 
embryo RNA used as positive controls were 26.3 ± 0.7 cycles, mean ± SEM, n = 3). Consistent with this, hete-
rozygous mutation of Pax3 (Pax3Sp2H/+) in the Splotch mouse, did not significantly alter trabecular bone struc-
ture and minimally affected cortical bone in the tibia of young male mice. None of the standard measures of 
trabecular bone mass and architecture were significantly different between Pax3Sp2H/+ and Pax3+/+ littermates 
(Supplementary Table S3).
Ct.Ar, Tt.Ar and PMI were unchanged between Pax3Sp2H/+ and Pax3+/+ littermates, whereas Ma.Ar was sig-
nificantly larger and Cs.Th was smaller (+4.8% and −7.1% on average across all sites respectively), primarily in a 
localised region of the distal tibia Supplementary Figure S1). None of the differences observed were site-specific 
(genotype * site interaction p > 0.10 in each case).
Figure 2. Vangl2Lp/+ mutation is associated with lower trabecular bone mass. µCT analysis of proximal tibial 
trabecular bone mass and architecture in 3-week-old male Vangl2+/+ and Vangl2Lp/+ littermates (n = 8 each). 
(A) Representative images of the proximal tibia showing less trabecular bone in the Vangl2Lp/+ tibia (arrows). 
Scale bar = 1 mm. B) BV/TV, (C) Tb.N, (D) Tb.Th, (E) Tb.Pf and (F) SMI were compared. *p < 0.05, **p < 0.01 
by independent samples t-test.
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Unlike the PCP mutants analysed above, eccentricity was not different between Pax3 genotypes 
(Supplementary Figure S1).
Mutation of the non-PCP gene Zic2 diminishes cortical bone structure. Zic2 mRNA expression 
increased in mineralising (day 21) relative to differentiating (day 7) osteoblasts and tended to increase in resorb-
ing (day 9) versus mature (day 7) osteoclasts (Supplementary Figure S2).
Heterozygous mutation of Zic2 (Zic2Ku/+) in the Kumba (Ku) mouse diminished cortical bone mass without 
altering trabecular bone in the tibia of young male mice. None of the standard measures of trabecular bone mass 
and architecture assessed were significantly different between Zic2Ku/+ and Zic2+/+ littermates (Supplementary 
Table S4). In cortical bone, SSA revealed that the tibia/fibula junction was significantly more proximal, as a per-
centage of the bone’s length, in Zic2Ku/+ than littermate Zic2+/+ (2.5% more proximal on average, Fig. 6A). Tibial 
length was unchanged (Supplementary Table S4). The shift in tibia/fibula junction position is clearly visible in 
SSA plots of tibial eccentricity, which show a sharp change at the point the tibia and fibula become separated 
(Fig. 6B). To account for this, the analysis of each tibia was adjusted such that the tibia/fibula junction was defined 
as being at 61% of the bones length (average junction position across the two genotypes). Applying this normal-
isation reduced the observed differences in cortical bone mass (e.g. at the 20% site of the proximal tibia, Ct.Ar 
was on average 34% lower in Zic2Ku/+ than littermate Zic2+/+ prior to normalisation and 27% lower following 
normalisation).
Following normalisation young male Zic2Ku/+ mice had lower Ct.Ar (−13.4% across all sites), Tt.Ar (−12.0% 
across all sites) and Ma.Ar (−6.5% across all sites) than Zic2+/+ littermates, with differences reaching significance 
Figure 3. Vangl2Lp/+ mutation is associated with regionally smaller cortical bone mass in the tibia of young 
male mice. SSA µCT analysis of cortical bone structure at each 1% site along the bone’s length in 3-week-
old male Vangl2+/+ and Vangl2Lp/+ littermates (n = 8 each). The tibia image indicates the orientation of SSA 
(proximal at 0% to distal at 100%). The tibia/fibula junction is indicated by the dashed vertical line (the fibula 
is automatically excluded from SSA). (A) Ct.Ar, (B) Tt.Ar, (C) Ma.Ar, (D) Cs.Th, (E) PMI and (F) eccentricity 
were quantified. (C’) Magnified view of marrow area quantification in the distal tibia. Green lines indicate 
regions of significant differences between genotypes by mixed model analysis with Bonferroni post-hoc.
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at various sites in the proximal tibia (Fig. 7A–C). The reduction in Tt.Ar was site specific (site * genotype inter-
action p = 0.045). Cs.Th was unchanged, but PMI was smaller (−17.6% across all sites) in tibiae of Zic2Ku/+ mice 
(Fig. 7D,E).
Although normalising the position of the tibia/fibula junction largely restored the otherwise marked apparent 
effect of the Zic2 mutation, eccentricity was nonetheless greater compared with Zic2+/+ littermates in the proxi-
mal tibia and immediately distal to the tibia/fibula junction (Fig. 7F).
Interlinked networks of genes involved in neural tube closure have skeletal functions. NTD 
determinants and bone-related functions share genetic networks which extend beyond PCP signalling and Zic2. 
259 genes were identified to be involved in mouse neural tube closure based on literature reviews published by 
Harris and Juriloff17,18 and genotypes annotated as having “abnormal neural tube closure” by the International 
Mouse Phenotyping Consortium or Deciphering Mechanisms of Developmental Disorders consortia (as of May 
2017, Fig. 8A). This NTD genes list is significantly enriched for biological processes containing “bone”, “osteoblast” 
Figure 4. Celsr1Crsh/+ mutation is associated with lower trabecular bone mass. µCT analysis of proximal 
tibial trabecular bone mass and architecture in 3-week-old male Celsr1+/+ and Celsr1Crsh/+ littermates (n = 8 
each). (A) Representative images of the proximal tibia showing less trabecular bone in the Celsr1Crsh/+ tibia 
(arrows). Scale bar = 1 mm. (B) BV/TV, (C) Tb.N, (D) Tb.Th, (E) Tb.Pf and (F) SMI were compared. *p < 0.05, 
**p < 0.01 by independent samples t-test.
www.nature.com/scientificreports/
7SCientifiC RepoRtS |  (2018) 8:3325  | DOI:10.1038/s41598-018-21718-x
or “osteoclast” terms (p < 0.05 in each case, Fig. 8B). These terms are associated with 46 genes (Supplementary 
Table S5) that indicate genetic commonalities between NTD phenotypes and skeletal functions. These 46 genes 
form an interlinked network (Fig. 8C) of genes with well-known functions in bone including secreted ligands or 
their receptors (e.g. Fgfr1, Bmp2, Wnt3a), intracellular signalling molecules (e.g. Rac1, Mapk8) and transcrip-
tional regulators (e.g. Rara/g, Msx1, Dlx5). Indeed, various signalling pathways with key functions in bone are 
significantly over-represented in this list (Fig. 8D). The most over-represented pathway is Wnt signalling (12 
genes, adjusted p < 1 × 10−13), including known components of the canonical Wnt pathway such as Wnt3a and 
Lrp6. Core components of the PCP pathway and Zic2 did not feature, reflecting the current lack of knowledge of 
these genes’ functions in bone.
Discussion
Here we tested the hypothesis that mouse genotypes predisposed to spina bifida independently have diminished 
bone mass. Hypothesis based selection of genes with well-established roles in neural tube closure confirmed that 
the PCP pathway contributes to trabecular bone mass, as well as implicating Zic2 in the determination of cortical 
bone mass. Unbiased bioinformatics analysis of genes known to be involved in neural tube closure identified 46 
genes with annotated roles in bone, primarily involving bone development and osteoblast functions. This demon-
strates genetic commonalities, at least in mice, between NTDs and bone properties. Implied functional common-
alities between NTDs and bone competence may compound with other fracture risk factors such as disuse and 
vitamin D deficiency in spina bifida patients9–11.
The importance of PCP signalling to skeletal development is clearly shown by limb dysmorphogenesis in 
Vangl2Lp/Lp embryos, Vangl2/Wnt5a double mutant embryos, and Prickle1 mutants23,24,33. However, the post-natal 
roles of PCP and specifically Vangl2 in bone are poorly understood. In order to confirm the potential relevance of 
PCP signalling to bone biology we first confirmed expression of several known core pathway components. While 
Figure 5. Celsr1Crsh/+ mutation is associated with regionally smaller cortical bone mass in the tibia of young 
male mice. SSA µCT analysis of cortical bone structure at each 1% site along the bone’s length in 3-week-old 
male Celsr1+/+ and Celsr1Crsh/+ littermates (n = 8 each). (A) Ct.Ar, (B) Tt.Ar, (C) Ma.Ar, (D) Cs.Th, (E) PMI and 
(F) eccentricity were quantified. (E’) µCT cross-sections through the tibia immediately distal to the tibula/fibula 
junction (62% site). Scale bar = 1 mm. Blue lines indicate regions of significant differences between genotypes 
by mixed model analysis with Bonferroni post-hoc.
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Vangl1 and Scrib were expressed at stable levels during osteoblastic differentiation in vitro, expression of both 
Vangl2 and Celsr1 increased significantly with differentiation and the onset of mineralisation. This is consistent 
with a previous report that deletion of the PCP downstream component Jnk1 diminishes late osteoblastic differ-
entiation in vitro and decreases bone formation in vivo34. In contrast, Vangl1 and Scrib expression increased in 
resorbing osteoclastic cells in vitro. What functions of these cells are promoted or inhibited by the PCP pathway 
is not known, but roles of this pathway in other cell types include coordination of cell migration35,36, extracellular 
matrix remodelling37, and organisation of the actin cytoskeleton38,39. This is consistent with our previous report 
that prevention of strain-related actin regulation by the PCP down-stream component ROCK, or mutation of 
Vangl2 in cortical osteoblasts from Lp mice, in each case prevented reorientation of cell division20. Of note, Vangl2 
protein follows a planar-polarised distribution along the proximal to distal axis of developing chondrocytes and 
WT Vangl2 protein retains this distribution in heterozygous Vangl2Lp/+ fetuses40, despite the Lp allele having 
dominant negative effects in other contexts41.
Analyses of Lp mice have delineated roles for Vangl2 in various organs including the lungs42 and kidneys43, 
in which it is involved in branching morphogenesis. It is therefore intriguing that Vangl2 mutation primarily 
diminishes bone mass in the branched, trabecular compartment, particularly as both of the PCP mutant gen-
otypes investigated here primarily had a reduced number of trabeculae. This finding is consistent between the 
femur of female mice previously reported20 and the tibia of male mice studied here. Vangl2 mutation had mini-
mal effects in the cortical compartment, which was extensively mapped using SSA in the present study thereby 
providing a more global representation of their skeletal phenotype than can be achieved by analysing individual 
sites. However, whereas Vangl2 mutation decreased eccentricity in the femoral midshaft20, it resulted in greater 
eccentricity in the proximal tibia. This discrepancy may be due to differences in muscle insertion between the two 
sites, or structural functional adaptations of the tibia such as those involved in stress damping given the reduction 
in proximal trabecular bone44,45.
Paradoxically, Celsr1 mutation mildly but significantly reduced eccentricity in the proximal tibia and around 
the tibia/fibula junction. Although the cellular or biomechanical bases for these differences are not known, they 
confirm that PCP signalling influences this parameter whereas, for example, the Pax3Sp2H mutation does not. 
Differences in cross-sectional eccentricity have previously been reported in human infants with spina bifida14, 
although it is not known whether these patients had mutations in PCP pathway components. Unique sequence 
variants in both VANGL2 and CELSR1 have been previously identified in human spina bifida patients46,47, but 
Figure 6. Heterozygous Zic2Ku/+ mutation is associated with a more proximally located tibia/fibula junction. 
(A) Quantification of the tibia/fibula junction as a percentage of bone length in Zic2+/+ and Zic2Ku/+ littermates 
(n = 8 each). (B) SSA analysis of eccentricity indicating the apparent shift in eccentricity associated with the 
more proximally-located tibia fibula junction in Zic2Ku/+ (cyan arrow) than Zic2+/+ (black arrow) littermates. 
(C) µCT cross-sections showing tibial structure at the 20% site and at the tibia/fibula junction in Zic2+/+ mice. 
The Zic2Ku/+ cross-sections are shown at the same percentage sites as the Zic2+/+ on the right and normalised 
to the position of the tibia-fibula junction (shifted by 3% of the bone’s length) on the left. Comparisons between 
Zic2+/+ and Zic2Ku/+ mice shown here were made following normalisation to the position of the tibia/fibula 
junction, but general reduction in cortical bone mass holds true if no correction is applied.
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to the authors’ knowledge skeletal structure has not been investigated in these patients. To our knowledge, all 
deleterious mutations in PCP genes associated with NTDs in humans reported to date have been identified in het-
erozygous patients, which is presumed to reflect multigenic aetiologies underlying these conditions48. Bone phe-
notypes identified in heterozygous mice in the present study may therefore be relevant to human NTD patients 
with heterozygous PCP mutations.
In the present study, mutation of Celsr1 in the Crsh mice was found to be associated with more marked reduc-
tion in cortical bone mass than Vangl2 mutation in Lp mice (i.e. 11.0% versus 3.3% reduction in Ct.Ar on average 
across all sites). A potential explanation for this is partial compensation for Vangl2 by Vangl149, although Vangl1 
does not compensate for Vangl2 during neural tube closure29. Cortical thickness was particularly reduced around 
the tibia/fibula junction of Celsr1Crsh/+ mice, where tissue area was reduced (suggesting diminished periosteal 
expansion) whereas the medullary area was increased (suggesting greater endosteal expansion in these rapidly 
growing mice). The cell-specific roles of Vangl2 and Celsr1 in the osteoblast and osteoclast lineage are not cur-
rently known and merit investigation through targeted deletion. Nonetheless, the findings presented here confirm 
that PCP signalling enhances post-natal bone mass, particularly in the trabecular compartment.
In contrast, the heterozygous Pax3Sp2H mutation had no significant effect on trabecular bone and minimal 
effects in the cortical compartment. Homozygous Pax3 mutation results in NTDs and also diminishes embryonic 
muscle development, which is associated with skeletal dysmorphology50. The interpretation that skeletal pheno-
types in homozygous Pax3 mutants are secondary to reduced muscle formation50 is consistent with our findings 
that Pax3 is not expressed at detectable levels in osteoblast or osteoclast cultures at various stages of differentia-
tion. Consequently, haploinsufficiency for Pax3 minimally altered tibial bone mass postnatally in male mice at the 
age investigated here despite these mice having detectable phenotypes in other organs; most notably the charac-
teristic white ventral skin spot which gives the line its name51. Given our analyses of young male mice, we cannot 
Figure 7. Zic2Ku/+ mutation is associated with significantly smaller cortical bone mass in the proximal tibia of 
young male mice. SSA µCT analysis of cortical bone structure at each 1% site along the bone’s length in 3-week-
old male Zic2+/+ and Zic2Ku/+ littermates (n = 8 each). (A) Ct.Ar, (B) Tt.Ar, (C) Ma.Ar, (D) Cs.Th, (E) PMI 
and (F) eccentricity were quantified. Blue lines indicate regions of significant differences between genotypes by 
mixed model analysis with Bonferroni post-hoc.
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exclude the possibility of deterioration (or indeed resolution) of skeletal phenotypes with age. Nonetheless, the 
young mice used in this study may be most relevant to paediatric cohorts. Fracture incidence in spina bifida 
patients, as in the general population, decreases in adulthood10.
As well as potentially contributing to a minority of spina bifida cases (at least in a Dutch population)52, ZIC2 
mutations are also directly associated with holoprosencephaly in humans53. We chose to study mutation of this 
gene because it causes fully penetrant spina bifida in mice54 and a polymorphism in it has previously been asso-
ciated with reduced hip bone mineral density in a Chinese population55. Unexpectedly, we observed that tibial 
structure in Zic2Ku/+ mice was substantially different from their littermate controls in that their tibia/fibula junc-
tion was more proximally positioned. The genetic and/or environmental control of this anatomical landmark is 
not known, in part because it is not commonly analysed, reflecting an additional advantage of the global SSA 
approach we have used. In addition, Zic2 mutation was associated with a significant reduction in cortical bone 
mass, site-specifically in the proximal region of the tibia. Intriguingly, this is the region of the tibia most respon-
sive to axial mechanical loading27 and the associated transcription factor Zic1 translocates to the nucleus follow-
ing mechanical stimulation of osteocyte-like cells in vitro56. Further work will be required to determine whether 
Zic transcription factors contribute to functional adaptation in vivo. An alternative mechanisms by which Zic2 
may influence bone mass includes its known regulation of hedgehog signalling, which plays diverse roles in skele-
tal physiology and pathology57. Zic2 binds with the hedgehog pathway transcriptional regulator Gli and promotes 
its nuclear translocation58. Both Gli3 and Ptch1, another member of the hedgehog pathway, featured in the list 
of genetic commonalities between NTDs and bone. Zic2 has also recently been reported to be over-expressed in 
osteosarcoma cells59, in which it promotes viability and migration through a PI3K/AKT-dependant mechanism. 
Whether Zic2 promotes the same processes in non-neoplastic osteoblastic cells is not known.
Despite our findings that Zic2Ku/+, Vangl2Lp/+ and Celsr1Crsh/+ mice all have significantly lower bone mass than 
their WT littermates, none of these genes featured in an unbiased analysis of the known commonality between 
Figure 8. Genetic commonalities between neural tube defects and bone-associated genes are enriched for 
pathways with critical skeletal functions. (A) Schematic of the processes by which the extent of known genetic 
commonality was determined. (B) “Bone”, “osteoblast” and “osteoclast” associated gene ontology terms enriched 
in the NTD genes list. (C) LinkDB map of interacting genes in the Overlap list. (D) Signalling pathways 
enriched in the Overlap list.
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the genetic networks involved in NTDs and bone. This reflects the current lack of knowledge of these genes’ 
roles in bone, contrasting with the well-established roles of canonical Wnt signalling which substantially influ-
ences processes including osteoblast differentiation60 and bones’ functional adaptation to mechanical loading61. 
Specific Wnt pathway components are now important clinical targets for the treatment of osteoporosis62. Human 
syndromes associated with high or low bone mass caused by mutations in Wnt pathway components are not, to 
our knowledge, associated with NTDs. However, this is unsurprising given redundant expression of some Wnt 
pathway components during development (e.g. Lrp5 and Lrp6 redundantly control embryonic skeletogenesis63) 
and bone-specific expression of other proteins (e.g. of sclerostin primarily in osteocytes64). Wnt signalling was 
the most prominently enriched pathway in the NTD/bone overlapping genes list, which included canonical Wnt 
pathway components. Although PCP and canonical Wnt branches may be mutually antagonistic in other con-
texts65, both appear to promote bone mass in mice.
In summary, this study confirms extensive commonalities between molecular networks involved in successful 
neural tube closure in mice and those that determine bone structure. Our findings extend these commonalities 
to include two core components of the PCP pathway, Vangl2 and Celsr1, as well as Zic2. Detailed analysis of 
tibial structure revealed that mutation of either PCP component substantially diminished trabecular bone mass, 
whereas Zic2 mutation diminished cortical bone in a site-specific manner. Importantly, each of these effects was 
seen following heterozygous mutation of the gene in question. In as far as these findings can be extrapolated to 
humans, they suggest heterozygous mutations in these pathways may predispose to low bone mass even in spina 
bifida patients whose neurodevelopmental defect has multi-allelic bases66. Extension of these findings through 
human genetic and clinical studies may allow stratification of patients at high risk of fracture in spina bifida 
cohorts, as well as in other conditions associated with mutations in these genes, and determine whether they 
substantially contribute to fracture risk in the wider population.
Methods
Mouse models. Studies were performed under project license number 70/7469 under the UK Animals 
(Scientific Procedures) Act 1986 and the Medical Research Council’s Responsibility in the Use of Animals for 
Medical Research (1993) in accordance with the relevant guidelines and regulations. All analyses were performed 
on 21 day old male mice sacrificed at the time of weaning, representing a rapidly-growing “paediatric” stage. 
Mutant and WT littermates were always included from each litter, analysing n = 8 of each genotype. Loop tail 
mice carry a mutation in Vangl267, Crash (Crsh) mice a mutation in Celsr129, Splotch (Sp2H) mice a deletion in 
Pax368, and Kumba (Ku) mice a mutation in Zic254 as previously described. Although heterozygous mutation 
of the genes analysed occasionally result in NTDs, only unaffected mice were used in this study. As expected all 
Vangl2Lp/+, all Celsr1Crsh/+ and one of the Zic2Ku/+ mice had looped or kinked tails believed to reflect secondary 
neurulation defects, whereas Pax3Sp2H/+ mice have a ventral area of depigmentation associated with defective 
neural crest migration.
Mouse body weights and tibial lengths were not significantly different between any of the mutants and their 
WT littermates at the age investigated (Supplementary Tables 1–4).
Bioinformatics analysis. Enriched gene ontology terms were identified using BiNGO analysis in 
Cytoscape69 as previously reported70. Interacting protein networks and KEGG pathway enrichments were iden-
tified and visualised using StringDB71. Network diagram links are based on experimental evidence and curated 
datasets, with line thickness indicating the strength of supporting data.
µCT and Site Specificity Analysis. Tibiae were dissected immediately following euthanasia and dehy-
drated in 70% ethanol. Tibiae were scanned using a Skyscan 1176 micro-CT scanner (Bruker microCT, Kontich, 
Belgium). All scans were taken at 50 kV, 500 µA with 0.5 mm aluminium filter, and 0.4° rotation step. Individual 
2D cross-sectional images were reconstructed using Bruker NRecon software version 1.6.10.2. Voxel resolution 
was 9 µm.
Trabecular analysis of the proximal tibia was performed by manually drawing around the trabecular region 
of interest as previously reported20, blinded to genotype. A 1 mm region starting 0.2 mm below the bottom of 
the growth plate was analysed and values for standard trabecular parameters are included in Supplementary 
Tables 1–4. Extensive cortical analysis was performed using SSA as previously described and validated27. SSA 
quantifies standard cross-sectional measures of bone mass and architecture at each one percent site of the bone’s 
length between 10% proximally and 90% distally. SSA data is shown as the mean ± SEM at each 1% site.
Osteoblast and osteoclast cultures. Osteoblasts were isolated from the calvariae of 3–5 day old C57BL/6 
mice by trypsin/collagenase digestion as previously described72,73. Cells were cultured for up to 21 days in alpha 
Minimum Essential Medium, (αMEM) supplemented with 2 mM β-glycerophosphate and 50 μg/ml ascorbic acid, 
with half medium changes every 3 days.
Osteoclasts were isolated from the long bones of 6–8 week-old C57BL/6 mice as described previously74. Cells 
were plated onto 5 mm diameter dentine discs (106 cells) in 96-multiwells in αMEM supplemented with 10% 
FCS, 5% gentamicin, 100 nM PGE2, 200 ng/ml M-CSF and 3 ng/ml receptor activator of nuclear factor ΚB ligand 
(RANKL, R&D Systems Europe Ltd, Abingdon, UK). After 24 hours, discs containing adherent osteoclast pre-
cursors were transferred to 6-well trays (4 discs/well in 4 ml medium) for a further 6 days. Culture medium was 
acidified to pH~7.0 by the addition 10 meq/l H+ (as HCl) on day 7 to activate resorption74 and osteoclasts were 
cultured for a further 2 days.
Total RNA extraction and DNase treatment. Osteoclasts were cultured on dentine discs for 7 (mature 
cells) or 9 days (mature, resorbing cells) before total RNA was extracted using TRIZOL® reagent (Invitrogen, 
Paisley, UK) according to the manufacturer’s instructions. Osteoblasts were cultured for 7 (differentiating), 14 
www.nature.com/scientificreports/
1 2SCientifiC RepoRtS |  (2018) 8:3325  | DOI:10.1038/s41598-018-21718-x
(mature) and 21 (mature, bone-forming) days before RNA collection. Extracted RNA was treated with RNase-free 
DNase I (35U/ml) for 30 min at 37 °C. The reaction was terminated by heat inactivation at 65 °C for 10 min. Total 
RNA was quantified spectrophotometrically by measuring absorbance at 260 nM. RNA was stored at −80 °C until 
amplification by qRT-PCR.
Quantitative real time polymerase chain reaction (qRT-PCR). Osteoclast and osteoblast RNA 
(50ng) was transcribed and amplified using the qPCRBIO SyGreen one-step qRT-PCR kit (PCR Biosystems, 
London, UK), which allows cDNA synthesis and PCR amplification to be carried out sequentially. qRT-PCR was 
performed according to manufacturer’s instructions with initial cDNA synthesis (45 °C for 10 min) and reverse 
transcriptase inactivation (95 °C for 2 min) followed by 40 cycles of denaturation (95 °C for 5 sec) and detection 
(60 °C for 30 sec). All reactions were carried out in triplicate using RNAs derived from 4–6 different cultures. 
Primer sequences (for/rev): Vangl1, acggagagtcccgcttctac/aattttccagaaccaccaagg: Vangl2, ccagccgcttctacaatgtc/
tctccaggatccacactgc: Celsr1, ggcagtcatgaccttggacta/agctgattcccaatctgcac: Scrib, ccaccacggaagaagatgac/gttattggcct-
ggtcaaacg: Zic2, tgcatgtccacacctcagat/gaggggaggactcatggac: Pax3, gcccacgtctattccacaa/gaatagtgctttggtgtacagtgc.
Statistical analysis. Bioinformatics comparisons were based on the standard false discovery rate corrections 
applied by the software. Comparisons between two groups were by t-test and between three groups by one way 
ANOVA. SSA comparisons were by mixed model analysis in IBM SPSS Statistics 22 accounting from repeated 
measures at different sites from each mouse testing the main effects of genotype and site with a genotype by site 
interaction (indicating site-specificity of effects) as previously reported27. When the overall genotype effect was 
significant a Bonferroni post-hoc correction was applied to identify sites of significant difference. P < 0.05 was 
considered significant.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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